PharmaAI at work across drug discovery, clinical trials and life sciences.
Research: AIM Research reports on Pharma AI →Page 23
With AI on the rise, securing data through encryption and strict controls is crucial. Experts highlight the need for transparency, ethics, and compliance to earn consumer trust. Discover essential insights on AI best practices.
A remarkable $36.7 billion in investment was given to AI companies in the United States in 2023, up from $22.7 billion in 2022, indicating the sector's durability and promise even in the face of wider economic uncertainty.
These advancements are poised to transform healthcare interactions, optimize investment management, and automate complex business processes, underscoring the far-reaching impact of AI across various sectors.
The technology, dubbed SmartAssist™, is designed to handle non-emergency calls without human intervention, potentially revolutionizing how 911 centers manage their increasing call volumes.
The research program will utilize Tempus Next, the company's AI-enabled care pathway intelligence solution, to deploy the algorithm at participating centers.
Today, the Clinical Research Group (CRG) at Thermo Fisher Scientific is thrilled to announce the appointment of Krishna Cheriath as the Chief Data, Analytics, and AI Officer.
In the world of technology, acquisitions are a common strategy for large companies to expand their capabilities, enter new markets, or eliminate competition. However, not all acquisitions lead to success.
Oracle today announced the general availability of the Oracle Clinical Digital Assistant for ambulatory clinics in the US.
Voicebrook, a pathology reporting solutions provider, has announced the release of DraftDiagnosis, a revolutionary generative AI feature that will help pathologists summarise diagnoses for cancer case reports.
By 2030, Americans over 50 are expected to spend over $200 billion annually on technology products, highlighting their considerable impact on the tech industry.
The AGI market, valued at $2.15 billion in 2022, is projected to reach $27.47 billion by 2030, growing at a CAGR of 37.5% .
CoAuthor, created by and for medical writers, offers simplicity of use with specialised AI models tailored to life sciences, solid client-specific GPT integration, and full eCTD regulatory writing templates.
Naveen's objective at Ardent Health is clear: to rethink how data drives enterprise-wide strategic decision-making.
The new advanced employee intelligence capabilities introduce real-time nudges and mobile alerts to aid decision-making and drive action at all levels of an organization.
Referral AI aims to solve this problem by using AI to scan and analyze referral documents in seconds, with customizable sensitivity settings to detect potential errors.
The integration aims to develop advanced AI-augmented diagnostic and interpretive capabilities, bridging biomedical innovation and care coordination.
The partnership aims to streamline clinical trial enrollment, reduce manual effort, and ultimately improve treatment options and outcomes through data-driven insights into patient experiences and real-world evidence.
CoAnalyst is meant to collaborate with analysts and investigators, interacting with their data to quickly provide analytical insights.
Centene Corporation, a prominent worldwide healthcare organisation, has recruited Wendy Batchelder as Senior Vice President and Chief Data Officer, in a strategic move to strengthen its data-driven efforts.
As companies harness the power of AI to revolutionize their respective fields, the future of technology looks increasingly interconnected and intelligent.